Press Release | NeoGenomics Laboratories

January 6, 2021

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

January 5, 2021

NeoGenomics Announces Proposed Public Offerings of Common Stock and Convertible Senior Notes

January 4, 2021

NeoGenomics To Virtually Participate In The 39th Annual J.P. Morgan Healthcare Conference

November 9, 2020

NeoGenomics to Offer Mobile Phlebotomy Services for Liquid Biopsy Tests

October 27, 2020

NeoGenomics Reports Revenue Growth of 20% to Record $125 Million in the Third Quarter

October 13, 2020

NeoGenomics Announces Plans to Expand Global Footprint in Pharma Services by Opening Clinical Research Laboratory in Suzhou, China

October 1, 2020

NeoGenomics Schedules Its Third Quarter Earnings Release for October 27, 2020

July 28, 2020

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients